Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the efficacy of quetiapine (Seroquel) in reducing
substance use in persons diagnosed with schizophrenia. The primary hypothesis is that
quetiapine treatment will be associated with a decrease in substance use.